The present application describes modulators of MCP-1 of formula (I): ##STR00001## or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.

 
Web www.patentalert.com

< Human DNAX toll-like receptor 4 proteins, related reagents and methods

> 17-acetamido-4-azasteroid derivatives as androgen receptor modulators

> Phenylurea derivatives as inhibitors of tyrosine kinases for the treatment of tumour diseases
~ 00597